<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="172709">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00847782</url>
  </required_header>
  <id_info>
    <org_study_id>CV198-001</org_study_id>
    <nct_id>NCT00847782</nct_id>
  </id_info>
  <brief_title>An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism</brief_title>
  <official_title>An Experimental Medicine Study to Quantify PCSK9 Serum Concentrations and LDL Receptor Expression in Peripheral Blood Cells in Normal and Hypercholesterolemic Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bristol-Myers Squibb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate novel assays for serum biomarkers of lipid
      metabolism (PCSK9 and LDL receptor) and to obtain information about how these biomarkers
      differ in subjects with normal or high cholesterol levels
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum PCSK9 concentration</measure>
    <time_frame>Initial assessment will occur when Group 1 has 50 subjects enrolled and Groups 2 and 3 have 30 subjects enrolled</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum LDL cholesterol concentration</measure>
    <time_frame>Initial assessment will occur when Groups 2 and 3 have enrolled 30 subjects</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum HDL cholesterol concentration</measure>
    <time_frame>Initial assessment will occur when Groups 2 and 3 have enrolled 30 subjects</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum TG concentration</measure>
    <time_frame>Initial assessment will occur when Groups 2 and 3 have enrolled 30 subjects</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Apo B concentration</measure>
    <time_frame>Initial assessment will occur when Groups 2 and 3 have enrolled 30 subjects</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Blood draw (Group 1)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Normocholesterolemic Subjects
Normal Healthy Volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood draw (Group 2)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hypercholesterolemic Subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blood draw (Group 3)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hypercholesterolemic Subjects with Statin Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <description>1 day</description>
    <arm_group_label>Blood draw (Group 1)</arm_group_label>
    <arm_group_label>Blood draw (Group 2)</arm_group_label>
    <arm_group_label>Blood draw (Group 3)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypercholesterolemia

          -  Statin monotherapy

        Exclusion Criteria:

          -  Significant acute or chronic illness

          -  Secondary causes of hypercholesterolemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bristol-Myers Squibb</last_name>
    <role>Study Director</role>
    <affiliation>Bristol-Myers Squibb</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W1R7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://ctr.bms.com/ctd/start.do</url>
    <description>BMS Clinical Trials Disclosure</description>
  </link>
  <link>
    <url>http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx</url>
    <description>Investigator Inquiry form</description>
  </link>
  <link>
    <url>http://www.fda.gov/MEDWATCH/safety.htm</url>
    <description>For FDA Safety Alerts and Recalls refer to the following link: http://www.fda.gov/MEDWATCH/safety.htm</description>
  </link>
  <verification_date>November 2009</verification_date>
  <lastchanged_date>November 4, 2009</lastchanged_date>
  <firstreceived_date>February 6, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Study Director</name_title>
    <organization>Bristol-Myers Squibb</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
